Not Yet RecruitingNot Applicable

Digital Remote Management for Care and Continuous Optimization Versus Usual Care to Reduce Risk of Atherosclerotic Cardiovascular Diseases (DigiCare-ASCVD)

China790 participantsStarted 2026-01

Plain-language summary

The DigiCare-ASCVD study is an investigator-initiated, multicenter, open-label, parallel-group randomized controlled trial. It aims to evaluated whether digital remote management is superior to usual care in reducing risk of atherosclerotic cardiovascular diseases and improving blood pressure control, glycemic control, lipids control, medication compliance and lifestyle.

Who can participate

Age range35 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. 10-year ASCVD risk ≥ 10%, calculated using the China-PAR risk prediction model
✓. Adultd aged ≥ 35 years
✓. Able to use a smartphone (or assisted by family) and agrees to remote management
✓. Signed informed consent

Exclusion criteria

✕. History of acute myocardial infarction, stroke, heart failure, malignant arrhythmia, or prior percutaneous coronary intervention or coronary artery bypass grafting surgery
✕. Moderate to severe hepatic dysfunction (Child-Pugh class B-C)
✕. CKD stages 4-5 (eGFR \<30 ml/min/1.73m²) or on dialysis
✕. Chronic obstructive pulmonary disease requiring ongoing home oxygen therapy or chronic oral steroid therapy as an outpatient
✕. Pregnant, planning to become pregnant within the next 12 months
✕. Life expectancy \<12 months (e.g., advanced malignancy, etc.);
✕. Cognitive impairment or communication disorder.

What they're measuring

Mean change in the patient's 10-year ASCVD risk, calculated using the China-PAR risk prediction model

Timeframe: 12 Months

Trial details

NCT IDNCT07332468

SponsorBeijing Anzhen Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2027-03

Contact for this trial

Liu He

13810720787 theliu@139.com

View on ClinicalTrials.gov More Atherosclerotic Cardiovascular Diseases trials